Ea. Engels et al., Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-Saharan Africa and Malta, INT J CANC, 88(6), 2000, pp. 1003-1008
Human herpesvirus 8 (HHV-8) is thought to be highly prevalent in Mediterran
ean countries and sub-Saharan Africa, where it causes Kaposi's sarcoma in a
small proportion of infected immunocompetent persons. However, the lack of
serological tests with established accuracy has hindered our understanding
of the prevalence, risk factors and natural history of HHV-8 infection. We
tested 837 subjects from Congo, Botswana (mostly young adults) and Malta (
elderly adults), using an immunofluorescence assay and 2 enzyme immunoassay
s (EIAs, to viral proteins K8.1 and orf65). Each assay found HHV-8 seroprev
alence to be high (49-87%) in the African populations and generally lower (
9-54%) in Malta. However, there was only modest agreement among tests regar
ding which subjects were seropositive (3-way kappa, 0.05-0.34). We used lat
ent class analysis to model this lack of agreement, estimating each test's
sensitivity and specificity and each population's HHV-8 prevalence. Using t
his approach, the K8.1 EIA had consistently high sensitivity (91-100%) and
specificity (92-100%) across populations, suggesting that it might be usefu
l for epidemiological studies. Compared with the K8.1 EIA, both the immunof
luorescence assay and the orf65 EIA Rad more variable sensitivity (80-100%
and 58-87%, respectively) and more variable specificity (57-100% and 48-85%
, respectively). HHV-8 prevalence was 7% among elderly Maltese adults. Prev
alence was much higher (82%) in Congo, consistent with very high Kaposi's s
arcoma incidence there. Prevalence was also high in Botswana (87% in Sans,
an indigenous group, and 76% in Bantus), though Kaposi's sarcoma is not com
mon, suggesting that additional co-factors besides HHV-8 are needed for dev
elopment of Kaposi's sarcoma. Int. J. Cancer 88:1003-1008, 2000, Published
2000 Wiley-Liss, Inc.dagger